MINAPHARM Pharmaceuticals

CASE:MIPH Stock Report

Market Cap: ج.م2.2b

MINAPHARM Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 2/6

MINAPHARM Pharmaceuticals has a total shareholder equity of EGP4.4B and total debt of EGP5.1B, which brings its debt-to-equity ratio to 114.1%. Its total assets and total liabilities are EGP11.8B and EGP7.4B respectively. MINAPHARM Pharmaceuticals's EBIT is EGP349.4M making its interest coverage ratio 0.7. It has cash and short-term investments of EGP3.2B.

Key information

114.1%

Debt to equity ratio

ج.م5.07b

Debt

Interest coverage ratio0.7x
Cashج.م3.20b
Equityج.م4.45b
Total liabilitiesج.م7.38b
Total assetsج.م11.83b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: MIPH's short term assets (EGP5.5B) exceed its short term liabilities (EGP4.7B).

Long Term Liabilities: MIPH's short term assets (EGP5.5B) exceed its long term liabilities (EGP2.6B).


Debt to Equity History and Analysis

Debt Level: MIPH's net debt to equity ratio (42.3%) is considered high.

Reducing Debt: MIPH's debt to equity ratio has increased from 79.2% to 114.1% over the past 5 years.

Debt Coverage: MIPH's debt is not well covered by operating cash flow (3.2%).

Interest Coverage: MIPH's interest payments on its debt are not well covered by EBIT (0.7x coverage).


Balance Sheet


Discover healthy companies